Hi @suranga:
Ultimately, all applications make use of data from across the CDM, but as
long as the tables exists (even if they have no data), all applications
should work without issue. So, no tables are ‘mandatory’ to populate, but
populating the tables will provide you more capabilities in the analytical
toolset.
In terms of using OHDSI tools to derive value for the OpenMRS community,
I’d imagine the next tool you may want to try to make operational is CIRCE
and CALYPSO. This would allow you to construct cohorts of patients that
satisfy specific inclusion criteria, and then use these cohorts for future
analysis. CALYPSO could let you assess the impact of each inclusion
criteria on the total number of persons eligible to be in your cohort.
CIRCE provides a user interface for defining the inclusion criteria, which
is then persists as JSON and compiles into SQL for your platform (here,
postgresQL). CIRCE allows for inclusion criteria to be constructed based
on any table of the CDM, but if you are thinking about building out a
staged approach to your ETL implementation, you could tackle specific
tables and then only use those features within CIRCE, and you shouldn’t
have any issues. In your case, as the slide suggests, if you were to
complete VISIT_OCCURRENCE and CONDITION_OCCURRENCE next, then you could
conduct analyses like: ‘how many patients came to clinic and diagnosed
with respiratory infection who had a prior diagnosis of HIV?’ If you take
the next step and populate the DRUG_EXPOSURE, you’ll be able to break that
down further by prior treatments.
Once you have CIRCE/CALYPSO working, you could then apply front-end tools
like HERACLES to characterize your cohorts (to answer questions like:
‘what are the demographics, comorbidities, concomitant medications of the
patients in my cohort?’), or back-end statistical analysis methods like
CohortMethod and SelfControlledCaseSeries for population-level estimation
if you have specific safety surveillance or comparative effectiveness
questions, or you could use PatientLevelPrediction to create individualized
risk estimates for the cohort.